293 related articles for article (PubMed ID: 21315695)
1. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
[TBL] [Abstract][Full Text] [Related]
2. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
[TBL] [Abstract][Full Text] [Related]
3. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
4. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.
Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH
Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182
[TBL] [Abstract][Full Text] [Related]
5. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
6. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.
Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X
Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Coats MT; Benjamin WH; Hollingshead SK; Briles DE
Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
[TBL] [Abstract][Full Text] [Related]
8. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
Moore QC; Bosarge JR; Quin LR; McDaniel LS
Vaccine; 2006 Jul; 24(29-30):5755-61. PubMed ID: 16759765
[TBL] [Abstract][Full Text] [Related]
9. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
10. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.
Denoël P; Philipp MT; Doyle L; Martin D; Carletti G; Poolman JT
Vaccine; 2011 Jul; 29(33):5495-501. PubMed ID: 21624422
[TBL] [Abstract][Full Text] [Related]
11. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
Villena J; Medina M; Racedo S; Alvarez S
J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge.
Gianfaldoni C; Censini S; Hilleringmann M; Moschioni M; Facciotti C; Pansegrau W; Masignani V; Covacci A; Rappuoli R; Barocchi MA; Ruggiero P
Infect Immun; 2007 Feb; 75(2):1059-62. PubMed ID: 17145945
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants.
Malekan M; Siadat SD; Aghasadeghi M; Shahrokhi N; Afrough P; Behrouzi A; Ahmadi K; Mousavi SF
J Med Microbiol; 2020 Mar; 69(3):465-477. PubMed ID: 32100705
[No Abstract] [Full Text] [Related]
14. Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.
Verhoeven D; Perry S; Pichichero ME
Clin Vaccine Immunol; 2014 Aug; 21(8):1037-45. PubMed ID: 24850621
[TBL] [Abstract][Full Text] [Related]
15. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
16. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
17. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism.
Visan L; Rouleau N; Proust E; Peyrot L; Donadieu A; Ochs M
Hum Vaccin Immunother; 2018 Feb; 14(2):489-494. PubMed ID: 29135332
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic protein contaminants in pneumococcal vaccines.
Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.
Verhoeven D; Xu Q; Pichichero ME
Vaccine; 2014 May; 32(26):3205-10. PubMed ID: 24731814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
